Jivi Intravenous and Risankizumab-rzaa topical

• Generic Name: antihemophilic factor
• Dosage Forms: n.a.
• Other Brand Names: Jivi, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Obizur

Antihemophilic factor (recombinant) pegylated-aucl injection is used to treat and control bleeding in patients with hemophilia A (congenital Factor VIII deficiency) who have been treated before. It is also used to reduce the number of bleeding episodes in patients when used regularly. Antihemophilic factor (recombinant) pegylated-aucl injection is also used to prevent bleeding during a surgical procedure.

This medicine is available only with your doctor's prescription.

• Generic Name: risankizumab
• Dosage Forms: n.a.
• Other Brand Names: Skyrizi

Risankizumab-rzaa is an interleukin-23 antagonist indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.